First Time Loading...

Inhibrx Inc
NASDAQ:INBX

Watchlist Manager
Inhibrx Inc Logo
Inhibrx Inc
NASDAQ:INBX
Watchlist
Price: 34.04 USD
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

INBX Price Targets Summary
Inhibrx Inc

Wall Street analysts forecast INBX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INBX is 36.21 USD with a low forecast of 35.35 USD and a high forecast of 37.8 USD.

INBX Lowest Forecast
Wall Street Target
35.35 USD
4% Upside
INBX Average Forecast
Wall Street Target
36.21 USD
6% Upside
INBX Highest Forecast
Wall Street Target
37.8 USD
11% Upside
Lowest
Price Target
35.35 USD
4% Upside
Average
Price Target
36.21 USD
6% Upside
Highest
Price Target
37.8 USD
11% Upside
Inhibrx Inc Competitors:
Price Targets
AFMD
Affimed NV
346% Upside
AMRN
Amarin Corporation PLC
32% Upside
603087
Gan & Lee Pharmaceuticals
22% Upside
2INV
2Invest AG
71% Downside
AFMD
Affimed NV
346% Upside
AMRN
Amarin Corporation PLC
32% Upside
603087
Gan & Lee Pharmaceuticals
22% Upside
2INV
2Invest AG
71% Downside
S
002880
Shenzhen Weiguang Biological Products Co Ltd
43% Upside
MGNX
MacroGenics Inc
68% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
17% Downside
A
298380
ABL Bio Inc
39% Upside

Revenue
Forecast

Revenue Estimate
Inhibrx Inc

For the last 5 years the compound annual growth rate for Inhibrx Inc's revenue is -27%. The projected CAGR for the next 3 years is 310%.

-27%
Past Growth
310%
Estimated Growth
Estimates Accuracy
15%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Inhibrx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Inhibrx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

See Also

Summary
INBX intrinsic value, competitors valuation, and company profile.
DCF Valuation
INBX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INBX stock valuation using valuation multiples.
Wall Street Estimates
INBX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INBX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INBX's stock price target?
Price Target
36.21 USD

According to Wall Street analysts, the average 1-year price target for INBX is 36.21 USD with a low forecast of 35.35 USD and a high forecast of 37.8 USD.

What is Inhibrx Inc's Revenue forecast?
Projected CAGR
310%

For the last 5 years the compound annual growth rate for Inhibrx Inc's revenue is -27%. The projected CAGR for the next 3 years is 310%.

ALPHA SPREAD
Join more than 133,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.